Harvard Medical Devices UK Limited - Filleted accounts

Harvard Medical Devices UK Limited - Filleted accounts


Registered number
06875329
Harvard Medical Devices UK Limited
Filleted Accounts
31 December 2022
Harvard Medical Devices UK Limited
Registered number: 06875329
Balance Sheet
as at 31 December 2022
Notes 2022 2021
£ £
Current assets
Debtors 3 1,075,504 725,834
Creditors: amounts falling due within one year 4 (6,195) (6,195)
Net current assets 1,069,309 719,639
Net assets 1,069,309 719,639
Capital and reserves
Called up share capital 190,002 190,002
Profit and loss account 879,307 529,637
Shareholders' funds 1,069,309 719,639
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
P L Griffith-Jones
Director
Approved by the board on 26 September 2023
Harvard Medical Devices UK Limited
Notes to the Accounts
for the year ended 31 December 2022
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2 Employees 2022 2021
Number Number
Average number of persons employed by the company 3 3
3 Debtors 2022 2021
£ £
Amounts owed by group undertakings and undertakings in which the company has a participating interest 1,075,504 725,834
4 Creditors: amounts falling due within one year 2022 2021
£ £
Trade creditors 1 1
Amounts owed to group undertakings and undertakings in which the company has a participating interest 6,194 6,194
6,195 6,195
5 Other information
Harvard Medical Devices UK Limited is a private company limited by shares and incorporated in England. Its registered office is:
Lockeridge House
Lockeridge
Marlborough
Wiltshire
SN8 4EL
Harvard Medical Devices UK Limited 06875329 false 2022-01-01 2022-12-31 2022-12-31 VT Final Accounts April 2022 P L Griffith-Jones No description of principal activity 06875329 2021-01-01 2021-12-31 06875329 core:WithinOneYear 2021-12-31 06875329 core:ShareCapital 2021-12-31 06875329 core:RetainedEarningsAccumulatedLosses 2021-12-31 06875329 2022-01-01 2022-12-31 06875329 bus:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 06875329 bus:AuditExemptWithAccountantsReport 2022-01-01 2022-12-31 06875329 bus:Director40 2022-01-01 2022-12-31 06875329 1 2022-01-01 2022-12-31 06875329 2 2022-01-01 2022-12-31 06875329 countries:England 2022-01-01 2022-12-31 06875329 bus:FRS102 2022-01-01 2022-12-31 06875329 bus:FullAccounts 2022-01-01 2022-12-31 06875329 2022-12-31 06875329 core:WithinOneYear 2022-12-31 06875329 core:ShareCapital 2022-12-31 06875329 core:RetainedEarningsAccumulatedLosses 2022-12-31 06875329 2021-12-31 iso4217:GBP xbrli:pure